XIAP and hematologic disorder: Having successfully established the feasibility of our pull down and in vitro expansion method for the detection of MiHA specific T-cells in small PBMC samples, we subsequently utilized the entire set of 333 PE-labeled pMHC tetramers to pull down MiHA specific T-cells from 20 HLA-A2 positive allo-SCT patients with various hematologic malignancies.